Ghost Tree Capital’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.76M | Sell |
60,000
-190,237
| -76% | -$5.59M | 0.53% | 44 |
|
|
2024
Q2 | $5.88M | Buy |
250,237
+150,237
| +150% | +$3.53M | 1.84% | 21 |
|
|
2024
Q1 | $3.79M | Buy |
+100,000
| New | +$3.79M | 1.05% | 28 |
|
|
2023
Q1 | – | Sell |
-32,000
| Closed | -$360K | – | 58 |
|
|
2022
Q4 | $360K | Sell |
32,000
-8,000
| -20% | -$90K | 0.15% | 35 |
|
|
2022
Q3 | $526K | Buy |
40,000
+3,000
| +8% | +$39.5K | 0.15% | 35 |
|
|
2022
Q2 | $467K | Buy |
37,000
+9,536
| +35% | +$120K | 0.24% | 27 |
|
|
2022
Q1 | $1.58M | Buy |
+27,464
| New | +$1.58M | 0.34% | 36 |
|
|
2016
Q4 | – | Sell |
-2,000
| Closed | -$321K | – | 78 |
|
|
2016
Q3 | $321K | Hold |
2,000
| – | – | 0.05% | 64 |
|
|
2016
Q2 | $243K | Buy |
+2,000
| New | +$243K | 0.07% | 48 |
|